Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for superior weight loss and glycemic control versus GLP-1-only agents. Research maps incretin co-agonism, adipose tissue remodeling, and cardiovascular outcome biomarker improvements.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
TR5
Peptide5mg × 10 vials (kit)
$85
TR10
Peptide10mg × 10 vials (kit)
$120
TR15
Peptide15mg × 10 vials (kit)
$130
TR20
Peptide20mg × 10 vials (kit)
$150
TR30
Peptide30mg × 10 vials (kit)
$190
TR40
Peptide40mg × 10 vials (kit)
$230
TR50
Peptide50mg × 10 vials (kit)
$270
TR60
Peptide60mg × 10 vials (kit)
$320
TR100
Peptide100mg × 10 vials (kit)
$400
TR120
Peptide120mg × 10 vials (kit)
$440
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord